Cargando…

Relative infectiousness of asymptomatic SARS-CoV-2 infected persons compared with symptomatic individuals: a rapid scoping review

OBJECTIVES: The aim of this study was to determine the relative infectiousness of asymptomatic SARS-CoV-2 infected persons compared with symptomatic individuals based on a scoping review of available literature. DESIGN: Rapid scoping review of peer-reviewed literature from 1 January to 5 December 20...

Descripción completa

Detalles Bibliográficos
Autores principales: McEvoy, David, McAloon, Conor, Collins, Aine, Hunt, Kevin, Butler, Francis, Byrne, Andrew, Casey-Bryars, Miriam, Barber, Ann, Griffin, John, Lane, Elizabeth Ann, Wall, Patrick, More, Simon John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8098293/
https://www.ncbi.nlm.nih.gov/pubmed/33947725
http://dx.doi.org/10.1136/bmjopen-2020-042354
_version_ 1783688444793323520
author McEvoy, David
McAloon, Conor
Collins, Aine
Hunt, Kevin
Butler, Francis
Byrne, Andrew
Casey-Bryars, Miriam
Barber, Ann
Griffin, John
Lane, Elizabeth Ann
Wall, Patrick
More, Simon John
author_facet McEvoy, David
McAloon, Conor
Collins, Aine
Hunt, Kevin
Butler, Francis
Byrne, Andrew
Casey-Bryars, Miriam
Barber, Ann
Griffin, John
Lane, Elizabeth Ann
Wall, Patrick
More, Simon John
author_sort McEvoy, David
collection PubMed
description OBJECTIVES: The aim of this study was to determine the relative infectiousness of asymptomatic SARS-CoV-2 infected persons compared with symptomatic individuals based on a scoping review of available literature. DESIGN: Rapid scoping review of peer-reviewed literature from 1 January to 5 December 2020 using the LitCovid database and the Cochrane library. SETTING: International studies on the infectiousness of individuals infected with SARS-CoV-2. PARTICIPANTS: Studies were selected for inclusion if they defined asymptomatics as a separate cohort distinct from presymptomatics and if they provided a quantitative measure of the infectiousness of asymptomatics relative to symptomatics. PRIMARY OUTCOME MEASURES: PCR result (PCR studies), the rate of infection (mathematical modelling studies) and secondary attack rate (contact tracing studies) - in each case from asymptomatic in comparison with symptomatic individuals. RESULTS: There are only a limited number of published studies that report estimates of relative infectiousness of asymptomatic compared with symptomatic individuals. 12 studies were included after the screening process. Significant differences exist in the definition of infectiousness. PCR studies in general show no difference in shedding levels between symptomatic and asymptomatic individuals; however, the number of study subjects is generally limited. Two modelling studies estimate relative infectiousness to be 0.43 and 0.57, but both of these were more reflective of the infectiousness of undocumented rather than asymptomatic cases. The results from contact tracing studies include estimates of relative infectiousness of 0, but with insufficient evidence to conclude that it is significantly different from 1. CONCLUSIONS: There is considerable heterogeneity in estimates of relative infectiousness highlighting the need for further investigation of this important parameter. It is not possible to provide any conclusive estimate of relative infectiousness, as the estimates from the reviewed studies varied between 0 and 1.
format Online
Article
Text
id pubmed-8098293
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-80982932021-05-10 Relative infectiousness of asymptomatic SARS-CoV-2 infected persons compared with symptomatic individuals: a rapid scoping review McEvoy, David McAloon, Conor Collins, Aine Hunt, Kevin Butler, Francis Byrne, Andrew Casey-Bryars, Miriam Barber, Ann Griffin, John Lane, Elizabeth Ann Wall, Patrick More, Simon John BMJ Open Epidemiology OBJECTIVES: The aim of this study was to determine the relative infectiousness of asymptomatic SARS-CoV-2 infected persons compared with symptomatic individuals based on a scoping review of available literature. DESIGN: Rapid scoping review of peer-reviewed literature from 1 January to 5 December 2020 using the LitCovid database and the Cochrane library. SETTING: International studies on the infectiousness of individuals infected with SARS-CoV-2. PARTICIPANTS: Studies were selected for inclusion if they defined asymptomatics as a separate cohort distinct from presymptomatics and if they provided a quantitative measure of the infectiousness of asymptomatics relative to symptomatics. PRIMARY OUTCOME MEASURES: PCR result (PCR studies), the rate of infection (mathematical modelling studies) and secondary attack rate (contact tracing studies) - in each case from asymptomatic in comparison with symptomatic individuals. RESULTS: There are only a limited number of published studies that report estimates of relative infectiousness of asymptomatic compared with symptomatic individuals. 12 studies were included after the screening process. Significant differences exist in the definition of infectiousness. PCR studies in general show no difference in shedding levels between symptomatic and asymptomatic individuals; however, the number of study subjects is generally limited. Two modelling studies estimate relative infectiousness to be 0.43 and 0.57, but both of these were more reflective of the infectiousness of undocumented rather than asymptomatic cases. The results from contact tracing studies include estimates of relative infectiousness of 0, but with insufficient evidence to conclude that it is significantly different from 1. CONCLUSIONS: There is considerable heterogeneity in estimates of relative infectiousness highlighting the need for further investigation of this important parameter. It is not possible to provide any conclusive estimate of relative infectiousness, as the estimates from the reviewed studies varied between 0 and 1. BMJ Publishing Group 2021-05-04 /pmc/articles/PMC8098293/ /pubmed/33947725 http://dx.doi.org/10.1136/bmjopen-2020-042354 Text en © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Epidemiology
McEvoy, David
McAloon, Conor
Collins, Aine
Hunt, Kevin
Butler, Francis
Byrne, Andrew
Casey-Bryars, Miriam
Barber, Ann
Griffin, John
Lane, Elizabeth Ann
Wall, Patrick
More, Simon John
Relative infectiousness of asymptomatic SARS-CoV-2 infected persons compared with symptomatic individuals: a rapid scoping review
title Relative infectiousness of asymptomatic SARS-CoV-2 infected persons compared with symptomatic individuals: a rapid scoping review
title_full Relative infectiousness of asymptomatic SARS-CoV-2 infected persons compared with symptomatic individuals: a rapid scoping review
title_fullStr Relative infectiousness of asymptomatic SARS-CoV-2 infected persons compared with symptomatic individuals: a rapid scoping review
title_full_unstemmed Relative infectiousness of asymptomatic SARS-CoV-2 infected persons compared with symptomatic individuals: a rapid scoping review
title_short Relative infectiousness of asymptomatic SARS-CoV-2 infected persons compared with symptomatic individuals: a rapid scoping review
title_sort relative infectiousness of asymptomatic sars-cov-2 infected persons compared with symptomatic individuals: a rapid scoping review
topic Epidemiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8098293/
https://www.ncbi.nlm.nih.gov/pubmed/33947725
http://dx.doi.org/10.1136/bmjopen-2020-042354
work_keys_str_mv AT mcevoydavid relativeinfectiousnessofasymptomaticsarscov2infectedpersonscomparedwithsymptomaticindividualsarapidscopingreview
AT mcaloonconor relativeinfectiousnessofasymptomaticsarscov2infectedpersonscomparedwithsymptomaticindividualsarapidscopingreview
AT collinsaine relativeinfectiousnessofasymptomaticsarscov2infectedpersonscomparedwithsymptomaticindividualsarapidscopingreview
AT huntkevin relativeinfectiousnessofasymptomaticsarscov2infectedpersonscomparedwithsymptomaticindividualsarapidscopingreview
AT butlerfrancis relativeinfectiousnessofasymptomaticsarscov2infectedpersonscomparedwithsymptomaticindividualsarapidscopingreview
AT byrneandrew relativeinfectiousnessofasymptomaticsarscov2infectedpersonscomparedwithsymptomaticindividualsarapidscopingreview
AT caseybryarsmiriam relativeinfectiousnessofasymptomaticsarscov2infectedpersonscomparedwithsymptomaticindividualsarapidscopingreview
AT barberann relativeinfectiousnessofasymptomaticsarscov2infectedpersonscomparedwithsymptomaticindividualsarapidscopingreview
AT griffinjohn relativeinfectiousnessofasymptomaticsarscov2infectedpersonscomparedwithsymptomaticindividualsarapidscopingreview
AT laneelizabethann relativeinfectiousnessofasymptomaticsarscov2infectedpersonscomparedwithsymptomaticindividualsarapidscopingreview
AT wallpatrick relativeinfectiousnessofasymptomaticsarscov2infectedpersonscomparedwithsymptomaticindividualsarapidscopingreview
AT moresimonjohn relativeinfectiousnessofasymptomaticsarscov2infectedpersonscomparedwithsymptomaticindividualsarapidscopingreview